These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 11258321

  • 1. [Prognostic factors influencing results of the surgical treatment of pancreatic cancer].
    Ignashov AM, Kokhanenko NIu, Lisochkin BG, Savrasov VM, Volkov ON, Dvorakovskaia IV, Lebedev EG, Kulikov IuV.
    Vestn Khir Im I I Grek; 2001; 160(1):33-6. PubMed ID: 11258321
    [Abstract] [Full Text] [Related]

  • 2. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC, Townsend CM, Nealon WH, Freeman JL, Riall TS.
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [Abstract] [Full Text] [Related]

  • 3. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K, Meyer F, Schmidt U, Lippert H.
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [Abstract] [Full Text] [Related]

  • 4. Carcinoma of the body and tail of the pancreas: is curative resection justified?
    Dalton RR, Sarr MG, van Heerden JA, Colby TV.
    Surgery; 1992 May; 111(5):489-94. PubMed ID: 1317976
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
    Shimada K, Sakamoto Y, Sano T, Kosuge T.
    Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.
    Bakkevold KE, Kambestad B.
    Eur J Surg Oncol; 1993 Apr; 19(2):147-61. PubMed ID: 7684003
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer.
    Boggi U, Del Chiaro M, Croce C, Vistoli F, Signori S, Moretto C, Amorese G, Mazzeo S, Cappelli C, Campani D, Mosca F.
    Surgery; 2009 Nov; 146(5):869-81. PubMed ID: 19744432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [Abstract] [Full Text] [Related]

  • 15. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C.
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [Abstract] [Full Text] [Related]

  • 16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [Abstract] [Full Text] [Related]

  • 17. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [Abstract] [Full Text] [Related]

  • 18. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Hepatogastroenterology; 2006 Oct; 53(69):447-51. PubMed ID: 16795990
    [Abstract] [Full Text] [Related]

  • 19. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
    Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR, van Gulik TM, Obertop H, Gouma DJ.
    Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
    [Abstract] [Full Text] [Related]

  • 20. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M, Nagakawa T, Ueno K, Ohta T, Kitagawa H, Arakawa H, Yagi H, Tajima H, Miwa K.
    Hepatogastroenterology; 1998 Mar; 45(21):827-32. PubMed ID: 9684142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.